【药物名称】
化学结构式(Chemical Structure):
参考文献No.69793
标题:Hypolipidemic and antioxidant morpholine derivs.
作者:Chrysselis, M.; Rekka, E.; Kourounakis, P. (Elpen Pharm. Co.)
来源:CA 2359476; EP 1140877; US 6693192; WO 0042030
合成路线图解说明:

Condensation of 4-bromoacetylbiphenyl (I) with N-methyl ethanolamine (II) leads to the 2-hydroxymorpholine (III). The acid-catalyzed reaction of the hemiketal (III) with 3-bromo-1-propanol (IV) gives the bromopropoxy morpholine (V), which is finally converted into the title nitrate ester by treatment with AgNO3 in acetonitrile. (1,2)

参考文献No.706856
标题:Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents
作者:Chrysselis, M.C.; Rekka, E.A.; Siskou, I.C.; Kourounakis, P.N.
来源:J Med Chem 2002,45(24),5406
合成路线图解说明:

Condensation of 4-bromoacetylbiphenyl (I) with N-methyl ethanolamine (II) leads to the 2-hydroxymorpholine (III). The acid-catalyzed reaction of the hemiketal (III) with 3-bromo-1-propanol (IV) gives the bromopropoxy morpholine (V), which is finally converted into the title nitrate ester by treatment with AgNO3 in acetonitrile. (1,2)

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us